SEC Comment Letter for Opus Genetics, Inc. (IRD) (CIK 0001228627) (IRD) — Mar 2, 2009

Opus Genetics, Inc. (IRD) (CIK 0001228627)
Date: March 2, 2009 · CIK: 0001228627 · Accession: 0000000000-09-010663

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-34079

Date

March 2, 2009

Author

Not clearly detected

Form

UPLOAD

Company

Opus Genetics, Inc. (IRD) (CIK 0001228627)

Letter

Via Facsimile and U.S. Mail Mail Stop 6010 March 2, 2009 Mr. Ted T.H. Jeong Rexahn Pharmaceuticals, Inc. Chief Financial Officer 9620 Medical Center Drive Rockville, Maryland 20850 Re: Rexahn Pharmaceuticals, Inc. Item 4.01 Form 8-K Filed March 2, 2009 File No. 001-34079

Dear Mr. Jeong:

We have completed our review of your Form 8-K and have no further comments at this time.

S i n c e r e l y ,

T a b a t h a A k i n s Staff Accountant

Show Raw Text

Via Facsimile and U.S. Mail Mail Stop 6010           March 2, 2009  Mr. Ted T.H. Jeong Rexahn Pharmaceuticals, Inc. Chief Financial Officer  9620 Medical Center Drive Rockville, Maryland  20850
Re: Rexahn Pharmaceuticals, Inc.
 Item 4.01 Form 8-K
Filed March 2, 2009
 File No. 001-34079

Dear Mr. Jeong:

We have completed our review of your Form 8-K and have no further comments
at this time.

        S i n c e r e l y ,

        T a b a t h a  A k i n s
Staff Accountant

SecProbe.io